Sep 11, 2018 US appeals court invalidates Acorda patents on MS drug US appeals court invalidates Acorda patents on MS drugA US appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door to generic ... read morePublished on 2018-09-11